• 1. An assay for the enzyme N-acetyl-β-d-glucosaminidase (NAGase) based on electrochemical detection using screen-printed carbon electrodes (SPCEs)
  R. M. Pemberton,J. P. Hart,T. T. Mottram Analyst, 2001,126, 1866-1871
• 2. An investigation of new infrared nonlinear optical material: BaCdSnSe4, and three new related centrosymmetric compounds: Ba2SnSe4, Mg2GeSe4, and Ba2Ge2S6?
  Kui Wu,Zhihua Yang,Shilie Pan Dalton Trans., 2015,44, 19856-19864
• 3. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
• 4. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 5. Aggregation of biologically important peptides and proteins: inhibition or acceleration depending on protein and metal ion concentrations
  Benjamin Gabriel Poulson,Kacper Szczepski,Joanna Izabela Lachowicz,Lukasz Jaremko,Abdul-Hamid Emwas,Mariusz Jaremko RSC Adv., 2020,10, 215-227

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azetidines

Comprehensive Overview of 1-Ethylazetidin-3-ol hydrochloride (CAS No. 1354940-66-1): Properties, Applications, and Industry Insights

1-Ethylazetidin-3-ol hydrochloride (CAS No. 1354940-66-1) is a specialized organic compound gaining attention in pharmaceutical and chemical research due to its unique structural features. As a derivative of azetidine, this compound belongs to the class of saturated heterocyclic compounds, which are increasingly explored for their potential in drug discovery and material science. The presence of both ethyl and hydroxyl groups on the azetidine ring makes it a versatile intermediate for synthesizing more complex molecules.

Recent studies highlight the growing demand for azetidine derivatives like 1-Ethylazetidin-3-ol hydrochloride in medicinal chemistry. Researchers are particularly interested in its role as a building block for bioactive molecules, especially those targeting neurological and metabolic disorders. The compound's polar functional groups enhance its solubility, making it suitable for aqueous reaction conditions—a critical factor in green chemistry initiatives. Industry reports suggest a compound annual growth rate (CAGR) of 8.2% for similar heterocyclic intermediates between 2023-2030, driven by advancements in small molecule therapeutics.

The synthesis of CAS 1354940-66-1 typically involves nucleophilic substitution reactions on azetidine precursors, followed by hydrochloride salt formation for improved stability. Analytical characterization through NMR spectroscopy and mass spectrometry confirms its high purity (>98%), meeting the stringent requirements of GMP-compliant manufacturing. Pharmaceutical companies frequently search for "high-purity azetidine suppliers" and "custom heterocyclic synthesis," reflecting the compound's commercial relevance.

Beyond pharmaceuticals, 1-Ethylazetidin-3-ol HCl finds applications in agrochemical research as a potential precursor for novel crop protection agents. Its molecular framework allows structural modifications that can influence biological activity—a key consideration for researchers investigating "structure-activity relationships" in pesticide development. The compound's thermal stability (decomposition point: 210-215°C) also makes it suitable for high-temperature reactions in material science applications.

Quality control protocols for 1354940-66-1 emphasize rigorous testing for residual solvents and heavy metals, addressing the pharmaceutical industry's focus on "impurity profiling." Storage recommendations typically specify airtight containers under inert gas at 2-8°C to maintain stability. These handling procedures align with broader industry trends toward standardized chemical storage practices and cold chain logistics for sensitive intermediates.

From a regulatory perspective, 1-Ethylazetidin-3-ol hydrochloride is not currently classified under restricted categories, facilitating its global trade. However, manufacturers increasingly provide "REACH-compliant documentation" and "custom synthesis reports" to meet evolving compliance requirements. The compound's low ecotoxicity profile (as per OECD 201/202 tests) further supports its sustainable use in research applications.

Emerging applications include its use in PET radiopharmaceuticals development, where the azetidine scaffold serves as a versatile platform for isotope labeling. This aligns with the growing market for diagnostic imaging agents, projected to exceed $12 billion by 2027. Researchers frequently search for "azetidine PET tracers" and "radiolabeling precursors," indicating strong interdisciplinary interest.

Technological advancements in continuous flow chemistry have enabled more efficient production of 1-Ethylazetidin-3-ol hydrochloride, reducing reaction times from hours to minutes while improving yield. This innovation addresses common industry queries about "scalable heterocycle synthesis" and "process intensification." Patent analysis reveals increasing filings involving this compound, particularly for kinase inhibitor formulations and allosteric modulator designs.

Market intelligence suggests that suppliers offering "research-grade azetidines" with comprehensive analytical data sheets gain competitive advantage. The compound's pricing reflects its high-value intermediate status, typically ranging $250-500/g for laboratory quantities. Bulk procurement options are becoming more available in response to demand from contract research organizations and academic consortia working on collaborative drug discovery projects.

Future research directions may explore the compound's potential in bioconjugation chemistry and proteolysis-targeting chimera (PROTAC) development—two rapidly growing areas in therapeutic innovation. The azetidine ring's conformational constraints offer unique opportunities for designing selective enzyme inhibitors, a frequent topic in recent scientific literature and conference proceedings.

• 36388-09-7(1-Dipropylamino-2-propanol)
• 54541-47-8((2-Hydroxypropyl)dimethylammonium chloride)
• 4402-32-8(1-Diethylamino-2-propanol)
• 5464-15-3(2-Propanol,1-(ethylmethylamino)-)
• 58901-12-5(2-Propanol,1,1',1''-nitrilotris-, hydrochloride (9CI))
• 2382-43-6(b-Methylcholine Chloride)
• 10353-86-3(1,1'-(2-Hydroxyethyl)iminobis-2-propanol)
• 106500-22-5(4-Azoniaspiro[3.3]heptane,2,6-dihydroxy-, chloride (9CI))
• 61363-19-7(1-Propanaminium,3-(dimethylamino)-N-[3-(dimethylamino)-2-hydroxypropyl]-2-hydroxy-N,N-dimethyl-, chloride)
• 122-20-3(Triisopropanolamine)